Journal
BRITISH JOURNAL OF PSYCHIATRY
Volume 192, Issue 2, Pages 86-87Publisher
ROYAL COLLEGE OF PSYCHIATRISTS
DOI: 10.1192/bjp.bp.107.045088
Keywords
-
Categories
Funding
- Medical Research Council [G0801747] Funding Source: researchfish
- MRC [G0801747] Funding Source: UKRI
- Medical Research Council [G0801747] Funding Source: Medline
Ask authors/readers for more resources
A drug acting at metabotropic glutamate receptors has recently been reported to be an effective antipsychotic, breaking the rule that only dopamine receptor-blocking drugs have this property. The finding complements accumulating evidence that glutamatergic abnormalities are important in the pathophysiology of schizophrenia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
